Bookmark and Share

Humana Reports Q3 Results; Raises Outlook (HUM)

Healthcare insurer, Humana Inc. (NYSE: HUM) on Monday reported a drop in fiscal third-quarter earnings as insurance claims increased sharply during the period; however, the company upwardly revised its outlook on fiscal 2012 earnings even as it agreed to acquire Metropolitan Health Networks in deal valued at $850 million.

For the fiscal third quarter which ended on September 30, the company reported net profit of $426 million or $2.62 a share, compared to net earnings of $ 445 million or $2.67 a share, in the year earlier quarter. However, the actual earnings beat company’s own initial estimates of $2.00 to $ 2.10 per share.  Analysts polled by Thomson Reuters had forecasted earnings of $2.05 a share.

The company said growth in earnings, to some extent, could be attributed to the fact that certain costs were shifted in the fourth quarter.

Meanwhile, thanks to higher premiums collected, revenue leaped 3.8% to $9.65 million from $9.3 million, in the corresponding period of last year. Nevertheless, revenue missed Street’s forecast of $9.86 million.

Bruce Broussard, who has been designated as the next Chief Executive following   Michael McCallister’s retirement from the company in January, said in a statement, “Our third-quarter results demonstrate that the issues which surfaced in the second quarter have stabilized,”

The insurer also announced that it has agreed to acquire Metropolitan Health Networks for $11.25 a share. The deal is expected to bolster Humana’s Medicare Advantage and Medicaid programs.

By the end of September, Humana’s Medicare Advantage program included over 1.9 million members–an increase of nearly 298,400 members from the year earlier quarter.

Human also raised its outlook on fiscal 2012 earnings. The company is now expecting earnings to fall within the range of $7.25 to $7.35 a share, up from its initial estimations of $6.90 to $7.10 a share. Potential improvements in earnings are attributed to stronger medical claims reserves and better stand –alone prescription drug plan results. Analysts’ consensual estimate on fiscal 2012 earnings is for $7.14 a share.

For fiscal 2013, the insurer is expecting earnings to come within the range of $ 7.60 to $ 7.80 a share, which is lower than Street’s expectations of $7.87 a share.


Leave a Reply

  

  

  

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


-------------------------------------------------------------------------------------------------------------------------
All stories in DailyStocks.com are for informational purposes only. This is NOT a stock recommendation. This DailyStocks.com story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at DailyStocks.com . About Dailystocks.com: DailyStocks.com is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.